Neonatal TPN order that may not survive mixing
A 1.2 kg preterm neonate on day 3 of life needs total parenteral nutrition through a central line. Fluid allowance is 120 mL/kg/day. The order reads: amino acids 3 g/kg/day, dextrose at a glucose infusion rate of 10 mg/kg/min, calcium gluconate 10 percent 4 mL, potassium phosphate providing phosphate in the same bag, plus standard electrolytes, trace elements and a separate 20 percent lipid emulsion at 3 g/kg/day. The prescribing team wants calcium and phosphate in the same compartment for 'convenience' and asks for the bag to be ready within the hour. Stock available: amino acid 10 percent, dextrose 50 percent, calcium gluconate 10 percent, potassium phosphate, lipid 20 percent.
1. Calculate the daily volumes of amino acid, dextrose and lipid for this baby, and comment on the dextrose concentration that results.
Read the worked answer
Total fluid: 120 mL/kg/day x 1.2 kg = 144 mL/day.
Amino acids: 3 g/kg x 1.2 kg = 3.6 g/day. From 10 percent solution (0.1 g/mL): 3.6 / 0.1 = 36 mL.
Dextrose: 10 mg/kg/min x 1.2 kg x 1440 min = 17,280 mg/day = 17.28 g/day. From 50 percent solution (0.5 g/mL): 17.28 / 0.5 = 34.56 mL, rounded to 34.6 mL.
Lipid: 3 g/kg x 1.2 kg = 3.6 g/day. From 20 percent emulsion (0.2 g/mL): 18 mL, given separately.
Comment on concentration: 17.28 g in roughly 144 mL is about 12 percent dextrose, which sits at the upper limit for peripheral administration; because this baby has a central line it is acceptable, but the number must be recomputed daily as fluid allowance and glucose infusion rate change. If the line were peripheral, the dextrose would need to be diluted and the fluid made up with more water or lipid.
Space left in the bag: 144 - 36 - 34.6 = about 73 mL for electrolytes, calcium, phosphate, trace elements and water. Always add the additive volumes before making up to the final volume, never after, or the bag is over-concentrated.
2. How would you handle the calcium and phosphate, and what sequence and checks would you use to make this bag safe?
Read the worked answer
The hazard: calcium and phosphate precipitate as insoluble calcium phosphate. In a neonate the risk is not theoretical - a precipitate can occlude the line or embolise, and it is often invisible in a opaque bag.
What I would do:
- Do not accept the 'convenience' request as written. Flag the order to the prescriber and, if possible, use an organic phosphate source (sodium glycerophosphate) or split calcium and phosphate between two bags/periods so the two never meet at high concentration.
- If both must be in one bag: maximise the amino acid concentration (amino acids buffer pH and improve compatibility), keep the bag cool, and add phosphate to the amino acid/dextrose mixture first, calcium last, with thorough mixing between every addition.
- Never draw calcium and phosphate into the same syringe or run them through the same line simultaneously.
- Add cysteine as ordered - it lowers pH and improves calcium-phosphate solubility.
- Inspect the finished bag against a black-and-white background under good light, before and after adding each component, and discard any bag showing haziness or particles.
- Filter: 0.22 micron for the aqueous solution; lipid through a 1.2 micron filter, and never through the same 0.22 micron filter.
- Label and beyond-use date: with a central line and an aseptic compounding service, a refrigerated bag is typically assigned a short beyond-use date (commonly 24 hours for a bag with additives, longer only if validated by the unit's stability data).
Reasoning to give the prescriber: compatibility here is a function of concentration, pH, temperature, order of mixing and the calcium-to-phosphate ratio - not of whether the two look fine in the bag.
3. Identify the sterility and process controls you would insist on before this bag leaves the unit, and explain why each matters in a 1.2 kg baby.
Read the worked answer
Environment: compounding in a validated laminar-airflow hood inside a cleanroom, with the hood surface decontaminated and the operator gowned, gloved and non-touch technique throughout. A 1.2 kg neonate has almost no physiological reserve, so a low-level contamination that a 70 kg adult would shrug off can cause sepsis or death.
Starting materials: check each additive for expiry, particulate matter and correct concentration; calcium gluconate 10 percent and potassium phosphate are look-alike ampoules, so read the label twice and have a second person verify.
Calculations and second check: independent double-check of every volume and dose by a second trained person before compounding and before release - a tenfold error in 0.5 mL is easy to make and impossible for the baby to tolerate.
Validation of the process: documented competency for neonatal TPN, use of a standard worksheet, and gravimetric or volumetric verification of the final weight/volume.
Release: visual inspection, filter integrity, correct label with full contents, rate, line, expiry date and time, and storage instructions.
Documentation: batch record, lot numbers, operator and checker signatures, so that a recall or an adverse event can be traced. Together these controls convert 'we made a bag' into 'we can prove the bag is what the label says it is'.